KZA 0.00% 8.0¢ kazia therapeutics limited

Dr Priscilla Brastianos, page-148

  1. 1,144 Posts.
    lightbulb Created with Sketch. 819
    Elkin Lecture - Priscilla Brastianos, MD - "Shifting Paradigms in Primary and Metastatic Brain Tumors: Unleashing the Power of Genomics to Clinical Care"

    CDK arm update in the ALLIANCE study was discussed.
    The PI3K arm was discussed using the previous slides for GDC-0084.
    Interesting response by Priscilla Brastianos in question time, about the possibility of using other drugs in combination with trial drugs, after the trial is completed,

    I look forward to the interim data from the brain mets Alliance trial in an abstract publication, maybe in the next AACR virtual meeting.

    Also looking forward to the interim data from Dana-Farber study using the combination of paxalisib and trastuzumab (herceptin) in BCBM.

    Regards.


 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.